Document Detail


Prophylactic total gastrectomy for individuals with germline CDH1 mutation.
MedLine Citation:
PMID:  20719348     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Germline mutation of the CDH1 gene, which encodes for the E-cadherin adhesion protein, is rare but confers an estimated lifetime risk of hereditary diffuse gastric cancer of 87%. Fewer than 100 prophylactic total gastrectomies have been reported for this condition.
METHODS: Patients with germline CDH1 mutation who underwent multidisciplinary counseling followed by prophylactic total gastrectomy were reviewed.
RESULTS: Ten patients (6 male, 4 female) with a median age of 42 years (range, 26-51) underwent prophylactic total gastrectomy between 2006 and 2009. Of the 6 families represented, there were 4 missense, 1 frameshift, and 1 splice site mutation. Median time from genetic testing to surgery was 3 months (range, 1-7). All patients had an upper endoscopy before surgery, identifying only 1 patient with a focus of diffuse gastric cancer. After prophylactic total gastrectomy, extensive pathologic analysis demonstrated that 9 patients had up to 77 foci of noninvasive cancer, and 2 of these patients had 4-12 foci of T1 invasive cancer. Median operative time was 213 minutes; there were no anastomotic leaks, and the length of stay was 7-8 days. One patient had a complication within 30 days (pulmonary embolism), and 3 patients had late complications (2 small bowel obstructions and 1 anastomotic stricture). Median weight loss at 6 months was 19%.
CONCLUSION: The majority of patients with germline CDH1 mutation have foci of noninvasive or invasive gastric cancer by middle age. Serial upper endoscopies provide inadequate screening. Prophylactic total gastrectomy is the procedure of choice for definitive treatment.
Authors:
Prakash K Pandalai; Greg Y Lauwers; Daniel C Chung; Devanshi Patel; Sam S Yoon
Related Documents :
697428 - Relief of acute, persistent postvagotomy atony by metoclopramide.
15650038 - Roux-en-y gastric bypass for clinically severe obesity: normal appearance and spectrum ...
6511168 - Long-term outcome after jejunoileal bypass for morbid obesity.
19656738 - Six-minute walk test: functional capacity of severely obese before and after bariatric ...
1542068 - Use of corticosteroids in oral surgery.
17208578 - Octreotide improved the quality of life in a child with malignant bowel obstruction cau...
Publication Detail:
Type:  Journal Article     Date:  2010-08-17
Journal Detail:
Title:  Surgery     Volume:  149     ISSN:  1532-7361     ISO Abbreviation:  Surgery     Publication Date:  2011 Mar 
Date Detail:
Created Date:  2011-02-21     Completed Date:  2011-04-12     Revised Date:  2012-02-16    
Medline Journal Info:
Nlm Unique ID:  0417347     Medline TA:  Surgery     Country:  United States    
Other Details:
Languages:  eng     Pagination:  347-55     Citation Subset:  AIM; IM    
Copyright Information:
Copyright © 2011 Mosby, Inc. All rights reserved.
Affiliation:
Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Anastomosis, Roux-en-Y
Cadherins / genetics*
Female
Gastrectomy*
Germ-Line Mutation*
Humans
Male
Middle Aged
Stomach Neoplasms / genetics*,  prevention & control
Chemical
Reg. No./Substance:
0/CDH1 protein, human; 0/Cadherins
Comments/Corrections
Comment In:
Surgery. 2012 Feb;151(2):342   [PMID:  22240148 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  IFN-g response to vaccination against tuberculosis in dairy heifers under commercial settings.
Next Document:  Different patterns of cancer incidence among African American and Caucasian renal allograft recipien...